ThermoGenesis Holdings, Inc. (NASDAQ:THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the pricing of its public offering of
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
ThermoGenesis Holdings (NASDAQ:THMO) brought in sales totaling $3.03 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 37.57%, resulting in a loss of $2.80 million.